Allergan gets subpoena on Botox promotion
NEW YORK (Reuters) - Allergan Inc said on Monday that it received a subpoena from the U.S. Department of Justice investigating the promotion of Botox, a drug best known for its cosmetic use.
<p><img src="http://feeds.reuters.com/~a/reuters/businessNews?i=lIfC5E" border="0"></img> (http://feeds.reuters.com/~a/reuters/businessNews?a=lIfC5E)</p><div class="feedflare">
<img src="http://feeds.reuters.com/~f/reuters/businessNews?i=twhQPTF" border="0"></img> (http://feeds.reuters.com/~f/reuters/businessNews?a=twhQPTF) <img src="http://feeds.reuters.com/~f/reuters/businessNews?i=3BlTlBf" border="0"></img> (http://feeds.reuters.com/~f/reuters/businessNews?a=3BlTlBf) <img src="http://feeds.reuters.com/~f/reuters/businessNews?i=gC34U3f" border="0"></img> (http://feeds.reuters.com/~f/reuters/businessNews?a=gC34U3f)
</div><img src="http://feeds.reuters.com/~r/reuters/businessNews/~4/245262691" height="1" width="1"/>
http://feeds.reuters.com/~r/reuters/businessNews/~3/245262691/idUSWEN430320080304